Biochemical pharmacology of Gilles de la Tourette's syndrome
Author:
- 28 February 1989
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 12 (3-4) , 295-305
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- The Inheritance of Gilles de la Tourette's Syndrome and Associated BehaviorsNew England Journal of Medicine, 1986
- Progabide in the treatment of hyperkinetic extrapyramidal movement disordersActa Neurologica Scandinavica, 1985
- The effects of naloxone in tourette's syndromeAnnals of Neurology, 1985
- Treatment of Multiple Tics and the Tourette SyndromeDevelopmental Medicine & Child Neurology, 1984
- Treatment of Tourette's Syndrome with RO22–1319, a D-2-Receptor AntagonistNew England Journal of Medicine, 1984
- DEANOL AND TOURETTE SYNDROMEThe Lancet, 1981
- Physostigmine in Gilles de la Tourette's SyndromeNew England Journal of Medicine, 1980
- Decreased serotoninergic activity in tourette syndromeAnnals of Neurology, 1979
- 5-Hydroxyindoleacetic Acid and Homovanillic Acid in Cerebrospinal Fluid of Patients with Neurological DiseasesEuropean Neurology, 1974
- Haloperidol therapy in tourette's syndrome: Neurophysiological, biochemical and behavioral correlatesLife Sciences, 1971